Abstract
The increase in global life expectancy, and consequently in the number of elderly people, emphasizes the problem of age-related pathologies. Among these pathologies, prostate cancer (PCa) is important due to its high incidence and lethality, with approximately 10,000 disease-associated deaths in Brazil every year. Since the most commonly used therapies to treat PCa, such as chemical and/…